Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine in Patients With Chronic Ischemic Heart Disease and Type 2 Diabetes
NCT00282360Phase 4Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Feb 1999
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in coronary artery disease (CAD) comparing Trimetazidine Arm with Placebo Arm (2 arms). Primary endpoints: Total ischemic burden at 6 months and Silent ischemia at 6 months. Started Feb 1999; status: completed.
02
Drugs
trimetazidine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00282360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00282360.